Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Agilent Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Agilent Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Agilent Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
Agilent Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Agilent Technologies Inc, Medical Equipment, Deal Details 16
Asset Purchase 16
Agilent Technologies Acquires Next Generation Sequencing IP Portfolio from Population Genetics Technologies 16
Dako To Acquire Intellectual Property Rights From System Dynamics 17
Venture Financing 18
NanoCellect Biomedical Raises USD10 Million in Series B Financing 18
Private Equity 19
Agilent Technologies Recommends Stockholders to Reject Mini-Tender Offer of TRC Capital 19
Partnerships 20
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 20
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool 21
Agilent Technologies Enters Into Licensing Agreement With Kreatech Diagnostics 22
Agilent Technologies and Agendia Enter into Agreement 23
Agilent Technologies Enters into Agreement with Burning Rock Biotech 24
Agilent Technologies Enters into Co-Marketing Agreement with Applied Spectral Imaging 25
Agilent Technologies Enters into Agreement with Eurofins Genomics 26
Agilent Technologies Enters into Agreement with 10X Genomics 27
Protea Biosciences Enters into Agreement with Agilent Technologies 28
Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 29
Merck and Pfizer Enters into Agreement with Dako 30
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 31
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 32
Agilent Extends Co-Marketing Agreement with MRM Proteomics 33
Dako Enters into Agreement with Merck for Companion Diagnostic Test 34
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 35
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 36
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics 37
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 38
Agilent Enters Into Research Agreement With Chungnam National University 39
Agilent Technologies Enters Into Co-Development Agreement With Florida International University 40
Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics 41
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 42
Agilent Technologies Enters Into Research Agreement With Ameritox 43
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 44
Advion Enters Into Technology Integration Agreement With Agilent Technologies 45
Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery 46
Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics 47
Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers 48
Dako Enters Into Co-Development Agreement With Amgen 49
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 50
Dako Enters Into Co-Development Agreement With Amgen 51
Dako Enters Into Co-Development Agreement With Bristol-Myers 52
Agilent Technologies Enters Into Co-Marketing Agreement With Bridge12 Technologies 53
Dako Denmark Enters Into Co-Development Agreement With Epitomics 54
Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies 55
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 56
Eppendorf Enters Into Licensing Agreement With Agilent Technologies 57
Debt Offering 58
Agilent Technologies Raises USD300 Million in Public Offering of Notes Due 2026 58
Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million 59
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 61
Asset Transactions 63
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 63
Persistent Systems Completes Acquisition Of Software Business From Agilent Technologies 64
Acquisition 65
Agilent Technologies Acquires Multiplicom for USD72 Million 65
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 66
Agilent Technologies Acquires Seahorse Bioscience for USD242 Million 67
Agilent Technologies Acquires Cartagenia for USD68.34 Million 68
Agilent Technologies To Acquire ABC Instrumentacion Analitica 69
Leica Biosystems Completes Acquisition Of Aperio Technologies 70
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 72
Agilent Technologies Completes Acquisition Of BioSystem Development 74
Agilent Technologies Acquires P.V.R. 75
Agilent Technologies Acquires Lab901 76
Agilent Technologies Inc – Key Competitors 78
Agilent Technologies Inc – Key Employees 79
Agilent Technologies Inc – Locations And Subsidiaries 81
Head Office 81
Other Locations & Subsidiaries 81
Recent Developments 83
Strategy And Business Planning 83
Jul 07, 2017: Agilent Technologies Opens New Customer & Technology Center in Waldbronn, Germany 83
Nov 30, 2016: Agilent Technologies Opens Folsom Technology Center 84
Financial Announcements 85
Nov 20, 2017: Agilent Technologies Reports Fourth-Quarter Fiscal Year 2017 Financial Results 85
Aug 15, 2017: Agilent Technologies Reports Third-Quarter Fiscal Year 2017 Financial Results 86
May 22, 2017: Agilent Technologies Reports Second-Quarter Fiscal Year 2017 Financial Results 87
Feb 14, 2017: Agilent Technologies Reports First-Quarter 2017 Results 88
Nov 15, 2016: Agilent Technologies Reports Fourth-Quarter 2016 Results 89
Aug 17, 2016: Agilent Technologies Reports Third-Quarter 2016 Results 90
May 16, 2016: Agilent Technologies Reports Second-Quarter 2016 Results 91
Feb 16, 2016: Agilent Technologies Reports First-Quarter 2016 Results 92
Corporate Communications 93
Jul 18, 2017: Hans E. Bishop to Join Agilent’s Board of Directors 93
May 04, 2017: Agilent Technologies Receives Multiple Awards at Scientific Conference in China 94
Mar 20, 2017: Agilent Technologies Hires Samraat “Sam” Raha to Head Strategy and Corporate Development 95
Mar 15, 2017: Agilent Technologies Board of Directors Elects Koh Boon Hwee as New Chairman 96
Mar 14, 2017: Agilent Technologies Receives 2017 Scientists’ Choice Award for Best Webinar Series 97
Feb 21, 2017: Agilent Technologies Receives Dow’s Western Canada Science and Technical Excellence Conference Awards (WesTEC) for Technical Excellence and Innovation 98
Dec 21, 2016: Agilent Technologies Receives Top Innovation Award from The Analytical Scientist 99
Mar 17, 2016: Agilent Technologies Receives Award for Outstanding Customer Service for Second Straight Year 100
Jan 27, 2016: Agilent Technologies Wins Award for Innovation in Liquid Chromatography 101
Jan 06, 2016: Agilent Technologies Names Michael Tang Senior Vice President, General Counsel and Secretary 102
Legal and Regulatory 103
Jan 11, 2017: Applied Spectral Imaging announced that its GenASIs applications comply with CE-IVD requirements with the IQFISH lung cancer panel on Dako Omnis of Agilent Technologies 103
Jan 06, 2016: ENZO Biochem Reaches $9 Million Patent Infringement Settlement with Agilent Technologies 104
Product News 105
Jun 19, 2017: Agilent Technologies Unveils New Analytical and Purification Solutions at HPLC 2017 105
Jun 05, 2017: Prosolia DESI 2D Molecular Imaging Now Compatible with Agilent Technologies 106
Oct 10, 2016: Agilent Technologies showcases innovative laboratory solutions at analytica China 2016 107
May 03, 2016: Agilent Technologies Introduces New Atomic Spectroscopy Platform for Multiple Analytical Applications 108
Apr 27, 2016: Agilent Technologies Statement – the Blueprint Project 109
Mar 09, 2016: Agilent Technologies Launches New Platform for Analyzing Cell-Free DNA 110
Jan 26, 2016: Agilent Technologies Showcases New Solutions at Biopharmaceutical Symposium 111
Other Significant Developments 112
Dec 21, 2016: Rubicon Genomics Signs Supply Agreement With Agilent Technologies For Its PicoPLEX WGA Kit 112
Oct 19, 2016: Jubilant Biosys Becomes the First Company in India to Install Agilent’s RapidFire/MS Screening Platform 113
Jul 28, 2016: Agilent Technologies Array CGH Platform Assures Quality of Cancer Cell Lines Used in Biomedical Research 114
Mar 14, 2016: Agilent Publishes Overview of Best Practices for Breast Cancer Diagnosis 115
Feb 11, 2016: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics 116
Feb 11, 2016: TRADE NEWS: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics 117
Jan 19, 2016: Agilent Technologies Extends Agreement with PerkinElmer on Bioanalyzer Chips 118
Appendix 119
Methodology 119
About GlobalData 119
Contact Us 119
Disclaimer 119
Agilent Technologies Inc, Medical Equipment, Key Facts, 2016 2
Agilent Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Agilent Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Agilent Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Agilent Technologies Inc, Deals By Market, 2011 to YTD 2017 11
Agilent Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Agilent Technologies Acquires Next Generation Sequencing IP Portfolio from Population Genetics Technologies 16
Dako To Acquire Intellectual Property Rights From System Dynamics 17
NanoCellect Biomedical Raises USD10 Million in Series B Financing 18
Agilent Technologies Recommends Stockholders to Reject Mini-Tender Offer of TRC Capital 19
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 20
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool 21
Agilent Technologies Enters Into Licensing Agreement With Kreatech Diagnostics 22
Agilent Technologies and Agendia Enter into Agreement 23
Agilent Technologies Enters into Agreement with Burning Rock Biotech 24
Agilent Technologies Enters into Co-Marketing Agreement with Applied Spectral Imaging 25
Agilent Technologies Enters into Agreement with Eurofins Genomics 26
Agilent Technologies Enters into Agreement with 10X Genomics 27
Protea Biosciences Enters into Agreement with Agilent Technologies 28
Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 29
Merck and Pfizer Enters into Agreement with Dako 30
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 31
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 32
Agilent Extends Co-Marketing Agreement with MRM Proteomics 33
Dako Enters into Agreement with Merck for Companion Diagnostic Test 34
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 35
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 36
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics 37
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 38
Agilent Enters Into Research Agreement With Chungnam National University 39
Agilent Technologies Enters Into Co-Development Agreement With Florida International University 40
Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics 41
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 42
Agilent Technologies Enters Into Research Agreement With Ameritox 43
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 44
Advion Enters Into Technology Integration Agreement With Agilent Technologies 45
Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery 46
Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics 47
Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers 48
Dako Enters Into Co-Development Agreement With Amgen 49
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 50
Dako Enters Into Co-Development Agreement With Amgen 51
Dako Enters Into Co-Development Agreement With Bristol-Myers 52
Agilent Technologies Enters Into Co-Marketing Agreement With Bridge12 Technologies 53
Dako Denmark Enters Into Co-Development Agreement With Epitomics 54
Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies 55
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 56
Eppendorf Enters Into Licensing Agreement With Agilent Technologies 57
Agilent Technologies Raises USD300 Million in Public Offering of Notes Due 2026 58
Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million 59
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 61
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 63
Persistent Systems Completes Acquisition Of Software Business From Agilent Technologies 64
Agilent Technologies Acquires Multiplicom for USD72 Million 65
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 66
Agilent Technologies Acquires Seahorse Bioscience for USD242 Million 67
Agilent Technologies Acquires Cartagenia for USD68.34 Million 68
Agilent Technologies To Acquire ABC Instrumentacion Analitica 69
Leica Biosystems Completes Acquisition Of Aperio Technologies 70
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 72
Agilent Technologies Completes Acquisition Of BioSystem Development 74
Agilent Technologies Acquires P.V.R. 75
Agilent Technologies Acquires Lab901 76
Agilent Technologies Inc, Key Competitors 78
Agilent Technologies Inc, Key Employees 79
Agilent Technologies Inc, Subsidiaries 81